Publications by authors named "Mitchell E Reff"

Claim this Profile
A
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.
Jianying Dong, Arlene Sereno, Dikran Aivazian, Emma Langley, Brian R Miller, Mitchell E Reff

MAbs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response.
Jianying Dong, Stephen J Demarest, Arlene Sereno, Susan Tamraz, Emma Langley, Mitchell E Reff

Mol Cancer Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved amino acid networks involved in antibody variable domain interactions.
Norman Wang, William F Smith, Brian R Miller, Dikran Aivazian, Alexey A Lugovskoy, Mitchell E Reff

Proteins· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
Adam Doern, Xianjun Cao, Arlene Sereno, Christopher L Reyes, Angelina Altshuler, Mitchell E Reff

J Biol Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel antibody hinge regions for efficient production of CH2 domain-deleted antibodies.
Scott M Glaser, Ina E Hughes, Jennifer R Hopp, Karen Hathaway, Daniel Perret, Mitchell E Reff

J Biol Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future of monoclonal antibodies in the treatment of hematologic malignancies.
Mitchell E Reff, Kandasamy Hariharan, Gary Braslawsky

Cancer Control· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD23 monoclonal antibody inhibits germline Cepsilon transcription in B cells.
Shingo Yabuuchi, Takehiko Nakamura, William S Kloetzer, Mitchell E Reff

Int Immunopharmacol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis